Collagen (I) homotrimer potentiates the osteogenesis imperfecta (oim) mutant allele and reduces survival in male mice

Type I collagen is the major structural component of bone where it exists as an (α1)2(α2)1 heterotrimer in all vertebrates. The osteogenesis imperfecta (oim) mouse model comprising solely homotrimeric (α1)3 type I collagen, due to a dysfunctional α2 chain, has a brittle bone phenotype implying that the heterotrimeric form is required for physiological bone function. However, humans with rare null alleles preventing synthesis of the α2 chain have connective tissue and cardiovascular abnormalities (cardiac valvular Ehlers Danlos Syndrome), without evident bone fragility. Conversely a prevalent human single nucleotide polymorphism leading to increased homotrimer synthesis is associated with osteoporosis. Whilst the oim line is well-studied, whether homotrimeric type I collagen is functionally equivalent to the heterotrimeric form in bone has not been demonstrated. Col1a2 null and oim mouse lines were used in this study and bones analysed by microCT and 3-point bending. RNA was also extracted from heterozygote tissues and allelic discrimination analyses performed using qRT-PCR. Here we comprehensively show for the first time that mice lacking the α2(I) chain do not have impaired bone biomechanical or structural properties, unlike oim homozygous mice. However Mendelian inheritance was affected in male mice of both lines and male mice null for the α2 chain exhibited age-related loss of condition. The brittle bone phenotype of oim homozygotes could result from detrimental effects of the oim mutant allele, however, the phenotype of oim heterozygotes is known to be less severe. We used allelic discrimination to show that the oim mutant allele is not downregulated in heterozygotes. We then tested whether gene dosage was responsible for the less severe phenotype of oim heterozygotes by generating compound heterozygotes. Data showed that compound heterozygotes had impaired bone structural properties as compared to oim heterozygotes, albeit to a lesser extent than oim homozygotes. Hence, we concluded that the presence of heterotrimeric collagen-1 in oim heterozygotes alleviates the effect of the oim mutant allele but a genetic interaction between homotrimeric collagen-1 and the oim mutant allele leads to bone fragility.

[1]  V. Escriou,et al.  Osteoblasts mineralization and collagen matrix are conserved upon specific Col1a2 silencing , 2020, Matrix biology plus.

[2]  T. Mazza,et al.  Cardiac valvular Ehlers‐Danlos syndrome is a well‐defined condition due to recessive null variants in COL1A2 , 2019, American journal of medical genetics. Part A.

[3]  M. Shoulders,et al.  A cysteine-based molecular code informs collagen C-propeptide assembly , 2018, Nature Communications.

[4]  Erin M. Mannen,et al.  Loss of RANKL in osteocytes dramatically increases cancellous bone mass in the osteogenesis imperfecta mouse (oim) , 2018, Bone reports.

[5]  Z. Shao,et al.  Association of COL1A1 rs1800012 polymorphism with musculoskeletal degenerative diseases: a meta-analysis , 2017, Oncotarget.

[6]  Simon W. Jones,et al.  Resistin promotes the abnormal Type I collagen phenotype of subchondral bone in obese patients with end stage hip osteoarthritis , 2017, Scientific Reports.

[7]  S. Fisher,et al.  The chaperone activity of 4PBA ameliorates the skeletal phenotype of Chihuahua, a zebrafish model for dominant osteogenesis imperfecta , 2017, Human molecular genetics.

[8]  J. Myllyharju,et al.  Structural basis of homo- and heterotrimerization of collagen I , 2017, Nature Communications.

[9]  A. Goodship,et al.  Counteracting bone fragility with human amniotic mesenchymal stem cells , 2016, Scientific Reports.

[10]  Joseph M. Wallace,et al.  Salubrinal improves mechanical properties of the femur in osteogenesis imperfecta mice. , 2016, Journal of pharmacological sciences.

[11]  D. Schlessinger,et al.  Novel action of FOXL2 as mediator of Col1a2 gene autoregulation. , 2016, Developmental biology.

[12]  S. Leikin,et al.  Osteoblast Malfunction Caused by Cell Stress Response to Procollagen Misfolding in α2(I)‐G610C Mouse Model of Osteogenesis Imperfecta , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  Joseph M. Wallace,et al.  Multi-scale analysis of bone chemistry, morphology and mechanics in the oim model of osteogenesis imperfecta , 2014, Connective tissue research.

[14]  R. Ritchie,et al.  How Tough Is Brittle Bone? Investigating Osteogenesis Imperfecta in Mouse Bone , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  Pavel Matousek,et al.  Evidence from Raman Spectroscopy of a Putative Link Between Inherent Bone Matrix Chemistry and Degenerative Joint Disease , 2014, Arthritis & rheumatology.

[16]  Henrik Westerberg,et al.  A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains , 2013, Genome Biology.

[17]  Jennifer R. Melander,et al.  Gender-Dependence of Bone Structure and Properties in Adult Osteogenesis Imperfecta Murine Model , 2013, Annals of Biomedical Engineering.

[18]  A. Boyde,et al.  Ultra-structural defects cause low bone matrix stiffness despite high mineralization in osteogenesis imperfecta mice☆ , 2012, Bone.

[19]  J. Harrow,et al.  A conditional knockout resource for the genome-wide study of mouse gene function , 2011, Nature.

[20]  Joan C. Marini,et al.  New perspectives on osteogenesis imperfecta , 2011, Nature Reviews Endocrinology.

[21]  S. Leikin,et al.  Chaperoning osteogenesis: new protein-folding disease paradigms. , 2011, Trends in cell biology.

[22]  Sandra J Shefelbine,et al.  Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties. , 2011, Blood.

[23]  Sejin Han,et al.  Carcinomas contain a matrix metalloproteinase-resistant isoform of type I collagen exerting selective support to invasion. , 2010, Cancer research.

[24]  Wolfgang Losert,et al.  Molecular Mechanism of Type I Collagen Homotrimer Resistance to Mammalian Collagenases* , 2010, The Journal of Biological Chemistry.

[25]  C. Cluzel,et al.  The Fibrillar Collagen Family , 2010, International journal of molecular sciences.

[26]  Wolfgang Losert,et al.  Segregation of type I collagen homo- and heterotrimers in fibrils. , 2008, Journal of molecular biology.

[27]  P. Byers,et al.  Defective C-propeptides of the Proα2(I) Chain of Type I Procollagen Impede Molecular Assembly and Result in Osteogenesis Imperfecta* , 2008, Journal of Biological Chemistry.

[28]  M. Noda,et al.  Ciz, a transcription factor with a nucleocytoplasmic shuttling activity, interacts with C-propeptides of type I collagen. , 2008, Biochemical and biophysical research communications.

[29]  C. T. Winkelmann,et al.  Role of genetic background in determining phenotypic severity throughout postnatal development and at peak bone mass in Col1a2 deficient mice (oim). , 2008, Bone.

[30]  Gerhard K. H. Przemeck,et al.  ER Stress-Mediated Apoptosis in a New Mouse Model of Osteogenesis imperfecta , 2007, PLoS genetics.

[31]  S. Leikin,et al.  Selective retention and degradation of molecules with a single mutant alpha1(I) chain in the Brtl IV mouse model of OI. , 2007, Matrix biology : journal of the International Society for Matrix Biology.

[32]  Timothy M. Wright,et al.  Abnormal Mineral-Matrix Interactions Are a Significant Contributor to Fragility in oim/oim Bone , 2007, Calcified Tissue International.

[33]  P. Bornstein,et al.  The NH2-terminal Propeptide of Type I Procollagen Acts Intracellularly to Modulate Cell Function* , 2006, Journal of Biological Chemistry.

[34]  J. V. van Meurs,et al.  Large-Scale Evidence for the Effect of the COLIA1 Sp1 Polymorphism on Osteoporosis Outcomes: The GENOMOS Study , 2006, PLoS medicine.

[35]  A. De Paepe,et al.  Total absence of the α2(I) chain of collagen type I causes a rare form of Ehlers-Danlos syndrome with hypermobility and propensity to cardiac valvular problems , 2005, Journal of Medical Genetics.

[36]  C. Franklin,et al.  Alpha 2(I) collagen deficient oim mice have altered biomechanical integrity, collagen content, and collagen crosslinking of their thoracic aorta. , 2005, Matrix biology : journal of the International Society for Matrix Biology.

[37]  K. Kadler,et al.  Procollagen trafficking, processing and fibrillogenesis , 2005, Journal of Cell Science.

[38]  Stuart J Warden,et al.  A comparison of mechanical properties derived from multiple skeletal sites in mice. , 2005, Journal of biomechanics.

[39]  S. Leikin,et al.  Changes in thermal stability and microunfolding pattern of collagen helix resulting from the loss of alpha2(I) chain in osteogenesis imperfecta murine. , 2003, Journal of molecular biology.

[40]  T J Sims,et al.  Properties of Collagen in OIM Mouse Tissues , 2003, Connective tissue research.

[41]  C. Franklin,et al.  Novel collagen glomerulopathy in a homotrimeric type I collagen mouse (oim). , 2002, Kidney international.

[42]  A. Bailey,et al.  Phenotypic expression of osteoblast collagen in osteoarthritic bone: production of type I homotrimer. , 2002, The international journal of biochemistry & cell biology.

[43]  P. Fratzl,et al.  Age- and genotype-dependence of bone material properties in the osteogenesis imperfecta murine model (oim). , 2001, Bone.

[44]  G. Davey Smith,et al.  Effect of a COL1A1 Sp1 Binding Site Polymorphism on Arterial Pulse Wave Velocity: An Index of Compliance , 2001, Hypertension.

[45]  T. Liem,et al.  The role of type I collagen in aortic wall strength with a homotrimeric. , 2001, Journal of vascular surgery.

[46]  R M Aspden,et al.  A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. , 2001, The Journal of clinical investigation.

[47]  D. A. Bradley,et al.  Oim mice exhibit altered femur and incisor mineral composition and decreased bone mineral density. , 2000, Bone.

[48]  A L Boskey,et al.  The Material Basis for Reduced Mechanical Properties in oim Mice Bones , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[49]  B. Brodsky,et al.  Altered collagen structure in mouse tail tendon lacking the α2(I) chain , 1997 .

[50]  P. Fratzl,et al.  Collagen from the osteogenesis imperfecta mouse model (oim) shows reduced resistance against tensile stress. , 1997, The Journal of clinical investigation.

[51]  N. Bulleid,et al.  Identification of the molecular recognition sequence which determines the type‐specific assembly of procollagen , 1997, The EMBO journal.

[52]  A G Patwardhan,et al.  Heterozygous oim mice exhibit a mild form of osteogenesis imperfecta. , 1996, Bone.

[53]  P. Byers,et al.  BiP binds type I procollagen pro alpha chains with mutations in the carboxyl-terminal propeptide synthesized by cells from patients with osteogenesis imperfecta. , 1993, The Journal of biological chemistry.

[54]  M T Davisson,et al.  Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[55]  S. Kimura Wide distribution of the skin type I collagen α3 chain in bony fish , 1992 .

[56]  D. Prockop,et al.  The clinical features of homozygous alpha 2(I) collagen deficient osteogenesis imperfecta. , 1984, Journal of medical genetics.

[57]  H. Ehrlich,et al.  Evidence for type V and I trimer collagens in Dupuytren's Contracture palmar fascia. , 1982, Biochemical medicine.

[58]  F. Pope,et al.  BIOCHEMICAL HETEROGENEITY OF OSTEOGENESIS IMPERFECTA: NEW VARIANT , 1979, The Lancet.

[59]  M Rojkind,et al.  Collagen types in normal and cirrhotic liver. , 1979, Gastroenterology.

[60]  B. Sykes,et al.  The estimation of two collagens from human dermis by interrupted gel electrophoresis. , 1976, Biochemical and biophysical research communications.

[61]  Patricia M. Cisarik,et al.  A Comparison , 1913, Texas medical journal.

[62]  E. Dall’Ara,et al.  Analysis of Bone Architecture in Rodents Using Micro-Computed Tomography. , 2019, Methods in molecular biology.

[63]  B. Brodsky,et al.  Altered collagen structure in mouse tail tendon lacking the alpha 2(I) chain. , 1997, Journal of molecular biology.

[64]  S. Kimura Wide distribution of the skin type I collagen alpha 3 chain in bony fish. , 1992, Comparative biochemistry and physiology. B, Comparative biochemistry.

[65]  D. Prockop Osteogenesis imperfecta. A model for genetic causes of osteoporosis and perhaps several other common diseases of connective tissue. , 1988, Arthritis and rheumatism.

[66]  P. Esposito,et al.  Osteogenesis Imperfecta. , 1928, Proceedings of the Royal Society of Medicine.